PeptiCanna has developed a novel patent-granted peptide that improves metabolic parameters for treating obesity and Diabetes type 2 without adverse central nervous system effects.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
PeptiCanna — Full Company Profile (machine-readable)
About
PeptiCanna has developed a novel patent-granted peptide that improves metabolic parameters for treating obesity and Diabetes type 2 without adverse central nervous system effects.
Facts
Name
PeptiCanna
Slug
pepticanna
Type
Israeli Startup
Founded
2019
HQ city
Rosh Haayin
HQ country
IL
Primary sector
[object Object]
Sectors
[object Object], [object Object], [object Object]
Business models
B2B
Target customers
[object Object], [object Object], [object Object]
Status
inactive
Current stage
Pre-Funding
Public stage
Pre-Funding
Total raised (USD)
0
Israeli Companies Registrar
516001328
Team (1)
Name
Role
LinkedIn
Andrea Heimann
Generate Slim Page
This site uses Google Analytics with anonymized IPs to understand which pages are useful. No personal profiling, no ads.